SyVento BioTech is excited to announce our participation in the highly anticipated 3rd Annual LNP Formulation & Process Development Summit taking place in Boston, MA, from April 29th to May 2nd, 2024. Our esteemed delegates, Dominik Lipka and Olga Długosz Grochowska, will be actively engaged in the summit, attending not only the core conference sessions but also delving deeper with participation in dedicated workshops about LNP Discovery & Screening and LNP Formulation & Delivery.

In the ever-evolving LNP landscape, the summit provides a comprehensive platform for gaining cutting-edge insights into the entire LNP development journey, from the initial in vitro discovery stages to the intricacies of large-scale, compliant manufacturing. The emphasis on end-to-end synergy aligns perfectly with SyVento BioTech’s commitment to delivering breakthrough mRNA therapeutics.

Key areas of focus for our delegates include:

  • Mastering next-generation formulation and delivery techniques to enhance stability and targeted drug delivery to specific organs.
  • Utilizing advanced process development and manufacturing methods to propel our LNP drug products to the forefront.
  • Identifying opportunities for fostering valuable collaborations within the dynamic LNP community.

By actively participating in this summit, SyVento BioTech aims to Stay ahead of the curve, gaining invaluable knowledge on the latest advancements in LNP formulation and processing. Drive Innovation by leveraging insights to refine our LNP development strategies and unlock the full potential of this powerful delivery platform and of course Enhance Patient Care contributing to the field of mRNA therapeutics by developing safe, efficacious, and innovative treatments that meet the highest quality and compliance standards.

We look forward to the exciting exchange of ideas and groundbreaking knowledge at the summit.

Follow us on X and LinkedIn for more updated content!